Drugs / TOL
last change Feb 2009 re-read 9 days ago

TOL

Developed for
allergic asthma
Investigated by
Laboratorios Leti, S.L.

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00622362 Jan 2008 → Feb 2009 allergic asthma Laboratorios Leti, S.L. Terminated No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TOL ClinicalTrials.gov intervention name — accepted as the source's own label NCT00622362 ↗